Primary dysmenorrhea (PD) is a common gynecological disorder. Hitherto, animal models which recapitulate clinical features of PD have not been fully established. We aimed to examine whether a pain model in mice could mimic the clinic features of PD. After pretreated with estradiol benzoate (1 mg/kg/day) intraperitoneally (i.p.) for 3 consecutive days, non-pregnant female Imprinting Control Region mice (6-8 weeks old) was injected with 0.4 U of oxytocin to induce the stretching or writhing response which was recorded for a time period of 30 min. During the writhing period, the uterine artery blood flow alterations were examined by Doppler ultrasound detection. After writhing test, the uterine morphological changes were observed by hematoxylin and eosin (H&E) staining histopathology. In addition, enzyme-linked immunosorbent assay kit was used to measure the levels of prostaglandins F2α/prostaglandins E2 (PGF2α/PGE2) and TXB2 (a metabolite of TXA2)/6-keto-PGF1α (a metabolite of PGI2) in the uterine tissue homogenates and plasma, respectively. Western blot analyses were performed to determine the expressions of oxytocin receptor (OTR), beta2-adrenergic receptor (beta2-AR), and cyclooxygenase-2 (COX-2) in uterine, which are responsible for the uterine contraction. The writhing response only occurred in the estrogen pretreated female mice. The area of uterine myometrium significantly decreased along with the increased thickness in the oxytocin-induced estrogen pretreated mice model. The uterine artery blood flow velocity dropped, while the pulsatility index and resistance index slightly increased after the injection of oxytocin. The PGF2α/PGE2 level significantly increased and the plasma TXB2/6-keto-PGF1α level significantly enhanced. Compared with the control group, the uterine histopathology demonstrated moderate to severe edema of endometrium lamina propria. In consistent with the uterine morphological changes, a significant reduction of beta2-AR and a significant increase of OTR and COX-2 in the uterine tissue were observed. The writhing response was caused by the abnormal contraction of uterus. The uterine spasm and ischemia changes of oxytocin-induced estrogen pretreated female mice model were similar to the pathology of human PD. We reported an in vivo mice model, which can be used to study PD and for clinical therapeutic evaluations.
Primary dysmenorrhea (PD) is a common gynecological disorder. Hitherto, animal models which recapitulate clinical features of PD have not been fully established. We aimed to examine whether a pain model in mice could mimic the clinic features of PD. After pretreated with estradiol benzoate (1 mg/kg/day) intraperitoneally (i.p.) for 3 consecutive days, non-pregnant female Imprinting Control Region mice (6-8 weeks old) was injected with 0.4 U of oxytocin to induce the stretching or writhing response which was recorded for a time period of 30 min. During the writhing period, the uterine artery blood flow alterations were examined by Doppler ultrasound detection. After writhing test, the uterine morphological changes were observed by hematoxylin and eosin (H&E) staining histopathology. In addition, enzyme-linked immunosorbent assay kit was used to measure the levels of prostaglandins F2α/prostaglandins E2 (PGF2α/PGE2) and TXB2 (a metabolite of TXA2)/6-keto-PGF1α (a metabolite of PGI2) in the uterine tissue homogenates and plasma, respectively. Western blot analyses were performed to determine the expressions of oxytocin receptor (OTR), beta2-adrenergic receptor (beta2-AR), and cyclooxygenase-2 (COX-2) in uterine, which are responsible for the uterine contraction. The writhing response only occurred in the estrogen pretreated female mice. The area of uterine myometrium significantly decreased along with the increased thickness in the oxytocin-induced estrogen pretreated mice model. The uterine artery blood flow velocity dropped, while the pulsatility index and resistance index slightly increased after the injection of oxytocin. The PGF2α/PGE2 level significantly increased and the plasma TXB2/6-keto-PGF1α level significantly enhanced. Compared with the control group, the uterine histopathology demonstrated moderate to severe edema of endometrium lamina propria. In consistent with the uterine morphological changes, a significant reduction of beta2-AR and a significant increase of OTR and COX-2 in the uterine tissue were observed. The writhing response was caused by the abnormal contraction of uterus. The uterine spasm and ischemia changes of oxytocin-induced estrogen pretreated female mice model were similar to the pathology of humanPD. We reported an in vivo mice model, which can be used to study PD and for clinical therapeutic evaluations.
Primary dysmenorrhea (PD) is a common gynecological disorder, affecting 40–50% adolescent
females of reproductive age [10]. This disease is
characterized by intense acute abdominal pain during the first or second day of the
menstrual flow yet without visible pelvic lesions [24]. These manifestations can be accompanied by symptoms such as low backache,
nausea, vomiting and diarrhea, which often lead to recurrent absence of school or work
[13]. Previous etiological studies have
demonstrated the close relationship between PD and abnormal increased prostanoid secretion
[7, 9]. The
abnormal prostanoid levels induce frequent or dysrhythmic uterine contractions, which can
reduce the uterine blood flow and be regarded as the main factors leading to menstrual pain
[4, 10].Although the abnormal levels of prostanoids have been proposed to be a major contributor to
the pain experience during PD, the pathological consequence still remains to be elucidated
[2]. Internationally, most of the studies regarding
PD were mainly relied on the in vitro experiments, which were confined to
investigate the local effects on the uterus, while the comprehensive effects were impossible
to be elucidated. In China, an in vivo mice model managed with oxytocin is
recognized as a pharmacodynamic experiment mice model and is frequently used in PD study
[15]. Since the intense acute abdominal pain is the
main clinical symptoms of PD, the writhing response was considered as the major indicator
and the writhing times were used to evaluate the model and the effects of the test drugs.
The comparative studies of this in vivo animal model mimicking the clinical
features of PD are scarce. In this study, we examined the pathological features of
oxytocin-induced estrogen pretreated female mice. We demonstrated that this pain model in
mice presented the increased level of PGF2α/PGE2, and increased
thickness along with the decreased area of uterine myometrium, as well as the uterine artery
blood flow velocity drop, which were similar to the pathological features of humanPD. The
abnormal contraction and ischemia of uterus were also confirmed by the histopathological and
biochemical measurements.
Material and Methods
Animals
Nonpregnant Female and Male Imprinting Control Region (ICR) mice weighing 18–22 g (6–8
weeks old) were obtained from the Experimental Animal Center of Yangzhou University. All
animals were housed in a temperature, humidity and light controlled vivarium, with food
and water ad libitum. Animal use protocol was approved by the Animal
Ethics Committee of the School of Chinese Material Medica, China Pharmaceutical
University.
Chemicals and reagents
Estradiol benzoate injection was obtained from Tianjin Jinyao Amino Acid Pharmaceutical
Co., Ltd. (Tianjin, China). Oxytocin was purchased from Nanjing Xinbai Pharmaceutical Co.,
Ltd. (Nanjing, China). Prostaglandin F2α (PGF2α), prostaglandin
E2 (PGE2), 6-keto-prostaglandin F1α (6-keto
PGF1α, a metabolite of PGI2) and thromboxane B2
(TXB2, a metabolite of TXA2) test kit were purchased from Nanjing
Jiancheng Bioengineering Institute Co., Ltd. (Nanjing, China).
Animal treatment and PD symptom recordings
Female and male mice were both pretreated with estradiol benzoate (1 mg/kg/day)
intraperitoneally for 3 consecutive days. Female mice with saline
exposure intraperitoneally were used as control group. On the fourth day, mice were
intraperitoneally injected with 0.4 U of oxytocin. Next, the writhing
responses, which mainly consisted of abdominal wall contractions, pelvic rotation, and
followed by hind limb stretches, were observed and recorded for 30 min. After the writhing
test, the animals were sacrificed by cervical dislocation. The areas of uterine myometrium
were calculated by Quantity One software, version 4.6.2 (Bio-Rad, USA), and then the
uterine tissues were collected for pathological and biochemical analysis.
Uterine artery blood flow analysis
Female mice were pretreated with estradiol benzoate (1 mg/kg/day) intraperitoneally for 3
consecutive days. On the fourth day, uterine artery blood flow of mice were monitored by
Doppler ultrasound detection (Ultrasound biomicroscope, Vevo2100TM, VisualSonics, Canada)
after the injection of oxytocin under 4% chloral hydrate anesthesia (10 ml/kg,
intraperitoneally).
Histological tests
After fixing the uterine tissues in 10% buffered formalin, the organs were dehydrated
with a graded ethanol series and embedded in paraffin. The uterine tissues were then
tailored into 5-µm-thick sections. The morphological evaluation of
tissues stained with hematoxylin and eosin (H&E) was performed with a light microscope
(OLYMPUS DX45, Japan).
Western blot analysis
Uterine tissue samples were prepared by homogenization in modified RIPA buffer (1×PBS, 1%
Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml PMSF, 30
µl/ml aprotinin, 100 mM sodium orthovanadate), and then maintained in
constant agitation for 1.5 h at 4°C and then centrifuged twice at
12,000 g for 5 min at 4°C. The supernatants were collected and the protein
concentration was determined by the BCA. Forty micrograms of total protein was applied to
each well of a 10% SDSpolyacrylamide gel and electrophoresed for 2 h at 120 V along with
a set of protein markers. The proteins were then transferred onto PVDF membranes
(Millipore Corp, Bedford, MA, USA) at 200 mA for 1.5 h at room temperature using a
transfer buffer (25 mmol/l Tris base, 192 mmol/l glycine and 20% methanol). The blots were
blocked for 1 h at room temperature with blocking buffer (in 10 mmol/l Tris, pH 7.5, 100
mmol/l NaCl, 0.1% Tween 20). The blocking buffer was decanted and blots were incubated
with primary antibody: anti-oxytocin receptor (anti-OTR, 1:200, sc-8102; SantaCruz
Biotechnology, Santa Cruz, CA, USA), anti-beta2-adrenergic receptor (anti-beta2-AR, 1:200,
sc-9042-; SantaCruz Biotechnology, Santa Cruz, CA, USA), anti-cyclooxygenase-2
(anti-COX-2, 1:1,000, ab62331; Abcam, USA). As an internal control, blots were incubated
with an anti-Glyceraldehyde 3-phosphate dehydrogenase antibody (anti-GAPDH, 1:5,000,
Shanghai Kangcheng Bioengineering Institute Co., Ltd., Shanghai, China). After washing
three times with TBS buffer (10 mmol/l Tris, pH 7.5, 100 mmol/l NaCl, 0.1% Tween 20), the
membrane was incubated with either a goat-anti-mouse or goat-anti-rabbit
peroxidase-conjugated secondary antibody depends on the source of primary antibody. The
blots were finally detected with ECL reagent and visualized by Quantity One software 4.6.2
(Bio-Rad, USA). Each experiment was repeated three times in order to have reproducible
results. The value of band intensity for the tested protein was normalized to the
intensity of GAPDH.
PGF2α, PGE2 and TXA2, PGI2
measurement
After retro-orbital collection of the blood, the mice were sacrificed by cervical
dislocation and the uterine tissues were then dissected for further investigation. The
uterine tissues were homogenized in 9 volumes of normal saline. Following centrifugation
at 3,000 rpm for 15 min at 4°C, the supernatant was used to measure the levels
of PGF2α, PGE2, 6-keto PGF1α (a metabolite of
PGI2) and TXB2 (a metabolite of TXA2) by enzyme-linked
immunosorbent assay (ELISA) in accordance with manufactures instructions (Nanjing
Jiancheng Bioengineering Institute Co., Ltd., Nanjing, Jiangsu, China).
Statistical analysis
All data are presented as means ± SEM. Statistical differences between paired groups were
calculated using Student’s t-test. The P<0.05 was
considered statistically significant. Data were represented graphically using GraphPad
Prism version 4 (GraphPad Software, San Diego, CA).
Results
Writhing Responses in estrogen pretreated mice
Oxytocin-induced writhing response only occurred during about 5–30 min after injection of
oxytocin in the females pretreated with estrogen while male mice did not experience any
writhing reactions (Fig. 1). The response mainly consisted of abdominal wall contractions, pelvic rotation,
and followed by hind limb stretches.
Fig. 1.
Oxytocin-induced writhing response in different sex and whether estrogen
pretreatment (n=12).“E+OT” group, the females and male mice were respectively
pretreated with estrogen (E) for 3 consecutive days and each mouse was injected with
0.4 U of oxytocin (OT) on the fourth day; “OT” group, the females and male mice were
respectively pretreated with saline for 3 consecutive days and each mouse was
injected with 0.4 U of oxytocin on the fourth day. The number of writhes was counted
for 30 min after oxytocin administration.
Oxytocin-induced writhing response in different sex and whether estrogen
pretreatment (n=12).“E+OT” group, the females and male mice were respectively
pretreated with estrogen (E) for 3 consecutive days and each mouse was injected with
0.4 U of oxytocin (OT) on the fourth day; “OT” group, the females and male mice were
respectively pretreated with saline for 3 consecutive days and each mouse was
injected with 0.4 U of oxytocin on the fourth day. The number of writhes was counted
for 30 min after oxytocin administration.
Area of uterine myometrium in oxytocin-induced writhing mice
As shown in Fig. 2, oxytocin induced a significant decrease on the area of the uterine myometrium
along with increased thickness.
Fig. 2.
Area of uterine myometrium in oxytocin-induced writhing mice. Pictures of uterine
myometrium in control and model group (A). The areas of uterine myometrium were
calculated by Quantity One software 4.6.2. (B) Data are presented as Means ± SEM
(n=5). Model group versus the control group ##P<0.01.
Statistical significance was analyzed by using Student’s
t-test.
Area of uterine myometrium in oxytocin-induced writhing mice. Pictures of uterine
myometrium in control and model group (A). The areas of uterine myometrium were
calculated by Quantity One software 4.6.2. (B) Data are presented as Means ± SEM
(n=5). Model group versus the control group ##P<0.01.
Statistical significance was analyzed by using Student’s
t-test.Example uterine artery Doppler
waveforms from normal mice and dysmenorrhea model mice. The uterine artery blood flow features in dysmenorrhea model mice.
Uterine artery blood flow features in oxytocin-induced writhing mice
As shown in Table 1, mean velocity of uterine artery blood flow decreased from 135.5 mm/s to
104.4 mm/s after intraperitoneal injection of oxytocin in model group, and the pulsatility
index raised 11.7%. Figure 3 presented a typical
image of uterine artery Doppler waveforms from dysmenorrhea model mice and control
mice.
Table 1.
Hemodynamic parameters of uterine vasculature evaluated by Doppler
ultrasound
Control
Model
Uterine artery
VTl, mm
18.67 ± 0.98
15.08 ± 0.77#
Maximum velocity, mm/s
211.5 ± 5.44
154.8 ± 6.90##
Mean velocity, mm/s
135.5 ± 7.03
104.4 ± 1.93##
Minimum velocity, mm/s
80.90 ± 4.43
54.45 ± 2.15##
Maximum gradient, mm Hg
0.179 ± 0.01
0.108 ± 0.006##
Mean gradient, mm Hg
0.0793 ± 0.006
0.0435 ± 0.002##
PI
0.897 ± 0.036
0.956 ± 0.036
RI
0.618 ± 0.017
0.646 ± 0.016
VTl indicates velocity-time integral of Doppler signal; PI, pulsatility index; RI,
resistance index. Data are presented as the mean ± SEM (n=6). Model group versus
control group #P<0.05
##P<0.01. Statistical significance was analyzed by
using Student’s t-test.
Fig. 3.
Example uterine artery Doppler
waveforms from normal mice and dysmenorrhea model mice. The uterine artery blood flow features in dysmenorrhea model mice.
VTl indicates velocity-time integral of Doppler signal; PI, pulsatility index; RI,
resistance index. Data are presented as the mean ± SEM (n=6). Model group versus
control group #P<0.05
##P<0.01. Statistical significance was analyzed by
using Student’s t-test.
PGF2α/PGE2 levels of oxytocin-induced writhing mice
The serum and uterine PGF2α/PGE2 ratio also significantly increased
53% and 46% in the model mice, respectively (Fig.
4).
Fig. 4.
Serum and uterine PGF2α/PGE2 levels of oxytocin-induced writhing mice.
PGF2α levels (A); PGE2 levels (B);
PGF2α/PGE2 levels (C). Data are presented as the Mean ± SEM
(n=10). Model group versus control group ##P<0.01.
Statistical significance was analyzed by using Student’s
t-test.
Serum and uterine PGF2α/PGE2 levels of oxytocin-induced writhing mice.
PGF2α levels (A); PGE2 levels (B);
PGF2α/PGE2 levels (C). Data are presented as the Mean ± SEM
(n=10). Model group versus control group ##P<0.01.
Statistical significance was analyzed by using Student’s
t-test.
TXA2/PGI2 levels of oxytocin-induced writhing mice
Figure 5 depicted that plasma TXB2 (a metabolite of
TXA2)/6-keto-PGF1α (a metabolite of PGI2) increased 36%
in the model group compared with the control group (P<0.05).
Fig. 5.
Plasma and uterine TXA2/PGI2 levels of oxytocin-induced writhing mice. TXB2 (a
metabolite of TXA2) levels (A); 6-keto PGF1α (a metabolite of PGI2)
levels (B); TXA2/PGI2 levels (C). Data are presented as the
Mean ± SEM (n=10), Model group versus control group
#P<0.05. Statistical significance was analyzed by
using Student’s t-test.
Plasma and uterine TXA2/PGI2 levels of oxytocin-induced writhing mice. TXB2 (a
metabolite of TXA2) levels (A); 6-keto PGF1α (a metabolite of PGI2)
levels (B); TXA2/PGI2 levels (C). Data are presented as the
Mean ± SEM (n=10), Model group versus control group
#P<0.05. Statistical significance was analyzed by
using Student’s t-test.
Histomorphology assessment of the uterus with H&E staining
As shown in Fig. 6A, the uterus histomorphology study of control groups showed no discernible
pathological changes under the light microscope at × 100 objective, while the model groups
showed moderate to severe edema in the endometrium lamina propria. Compared with the
control group, the number of uterine glands has no obvious increase, but the amount of
deep eosin dye homogeneous secretions presented in the glandular lumens in model mice.
Fig. 6B showed the pathological score in
control and model group. The scoring system of pathological change presented in the
supplementary data 1.
Fig. 6.
Pathological change in uterus. (A) Example pathological section of the uterus;
H&E staining. No discernible pathological changes were observed in the control
group, some inflammatory pathological changes were observed in the model group. (B)
Pathological score of uterus in control and model group. Data are presented as the
Mean ± SEM (n=6). Model group vs control group
##P<0.01. Statistical significance was analyzed by
using Student’s t-test.
Pathological change in uterus. (A) Example pathological section of the uterus;
H&E staining. No discernible pathological changes were observed in the control
group, some inflammatory pathological changes were observed in the model group. (B)
Pathological score of uterus in control and model group. Data are presented as the
Mean ± SEM (n=6). Model group vs control group
##P<0.01. Statistical significance was analyzed by
using Student’s t-test.
Expressions of OTR, COX-2 and beta2-AR in uterus of oxytocin-induced writhing
mice
A significant increase of oxytocin receptor (OTR, functional protein of uterine
contraction) and a significant reduction of beta 2-adrenergic receptor (beta2-AR,
functional protein of uterine relaxation) were observed in uterine tissue.The uterine
cyclooxygenase-2 (COX-2) expression of oxytocin-induced model mice significantly increased
by approximately 70% compared with the control mice (Fig. 7).
Fig. 7.
Uterine oxytocin receptor, COX-2 and beta 2-AR protein expression in the
oxytocin-induced writhing mice. Data illustrated on the graph bar represent the mean
± SEM for six uterus in each group (n=6). Model group vs. control group
##P<0.01. Statistical significance was analyzed by
using Student’s t-test.
Uterine oxytocin receptor, COX-2 and beta 2-AR protein expression in the
oxytocin-induced writhing mice. Data illustrated on the graph bar represent the mean
± SEM for six uterus in each group (n=6). Model group vs. control group
##P<0.01. Statistical significance was analyzed by
using Student’s t-test.
Discussion
As far as the existing PD models concerned, they are usually initiated by different
stimulators, such as PGF2α and oxytocin on isolated uterine horn [18, 20]. All of
these isolated organ models focused on the local effects on uterus instead of the whole
animal. Since the pathogenesis of PD related to hypothalamic-pituitary-ovarian axis [5, 11], thus the
comprehensive therapeutic effects of the test drugs or the pathological mechanisms of PD
were difficult to be elucidated by the isolated uterine horn model. An ideal animal model is
expected to remedy the defects of the in vitro isolated uterine horn model.
In China, the oxytocin-induced writhing mouse model, a frequently-used pain model in mice,
was used to evaluate the anti-dysmenorrhea effects of Chinese herbal medicine, which has
been used to prevent and cure PD since ancient times.Although the complete PD disease process is not yet understood, PD in humans being due to
uterine spasm contraction and focal ischemia has been recognized. Clinically, various
studies of quantitative measurement of the area of myometrium at times of maximum and
minimum pain in dysmenorrheic and eumenorrheic groups demonstrated that the area of the
uterine myometrium, which represents the contraction ratio, significantly decreased during
days 1–3 of the menstrual cycle in the dysmenorrheic group [17]. Oxytocin is a small peptide hormone to stimulate uterine contractions through
functionally coupling to oxytocin receptor (OTR) [23]. OTR over expressed when activated by estrogen, and the concentrations of OTR
determine the sensitivity of endometrium to oxytocin stimulation [14]. In the present study, oxytocin-induced writhing responses only
occurred in the female mice pretreated with estrogen, and a significant decrease of
myometrium area was observed. Our results showed increased uterine OTR expression in mice
model pretreated with estrogen and proved the writhing responses of this pain model in mice
were caused by abnormal contraction of the uterus. The results were consistent with the
clinical findings and further illustrated the contraction of the target organ in
vivo as a symptom of PD.Moreover, the clinical studies have shown that the pulsatility index and resistance index
of both uterine arteries, as well as the arcuate artery are significantly higher on the
first menstrual day in women with PD, suggesting the paradox of increased blood flow
impedance and uterine vasoconstriction may be the cause of PD [10]. Reduced uterine blood flow, possibly caused by strong and abnormal
uterine contractions in dysmenorrheic women, results in myometrial ischemia and produces
cramp-like pain. A report on the measurement of blood flow in the uterine artery with
Doppler US also indicated that uterine artery resistance was significantly higher in
subjects with dysmenorrhea than in those asymptomatic controls, and thus supported the idea
that ischemia is another cause of PD [19]. Our study
demonstrated that oxytocin-induced uterine artery blood flow velocity dropped distinctly,
while the pulsatility index and resistance index slightly increased in model mice, which
were in accordance with the clinical features of PDpatients.In addition, Prostaglandins signaling have been proved to directly affect the uterine
contraction, which are possibly the main reasons for PD [6, 21]. Clinical studies have demonstrated
that PGF2α levels of PDpatients are much higher than those of asymptomatic
controls, therefore the increased level of PGF2α/PGE2 have been
regarded as the indicator of clinical diagnosis for PD [9, 16]. Our study also demonstrated that
the serum and uterine PGF2α/PGE2 ratio significantly increased 53 and
46% in the model group.In addition, clinical reports also suggested that increased oxytocin receptor (OTR)
expression occurs in PDpatients. OTR is functionally coupled to Gαq/11 as well
as Gαi in myometrial cells and mediates uterine contraction [1, 3, 26]. On the contrary, beta2-AR is predominantly a Gαs-coupled receptor and
mediates uterine relaxation via an increase in intracellular cAMP levels. The mechanisms
underlying crosstalk between the two receptors have been investigated and the relationship
with PKCζ was reported, which is involved in the OTR and beta2-AR mediating ERK1/2
activation, respectively [12]. Our data demonstrated
that uterine OTR expression was significantly increased and beta2-AR expression was
significantly decreased in the oxytocin-induced estrogen pretreated mice model, providing an
explanation for the abnormal uterine contraction.After comfirmed the abnormal spasm contraction and ischemia of uterus in the
oxytocin-induced estrogen pretreated mice model, further investigations were made through
the histopathological and biochemical measurements. The results showed the model group
presented moderate to severe edema in endometrium lamina propria, the number of uterine
glands changed little, but the amount of deep eosin dye homogeneous secretions presented in
the glandular lumens suggesting that the oxytocin-induced writhing model was possibly a
visceral and inflammatory pain model. Prostaglandins and prostanoids are biosynthesized from
arachidonic acid through the COX pathway after production of arachidonic acid from
hydrolysis of phospholipids by phospholipase [22].
Myometrial cells could synthesize both PGF2α and PGE2 and be regulated
by steroids through a transcription-independent manner, which modulated the effect of OT on
COX-2 expression [8, 25]. Our study demonstrated that COX-2 protein was over expressed in
oxytocin-induced mice model, providing some evidence that oxytocin-induced writhing response
might be a COX-2 dependent inflammatory response.Thromboxane A2 (TXA2) produced by activated platelets and has
prothrombotic properties, stimulates activation of new platelets as well as accelerates
platelet aggregation. Prostacyclin (PGI2) was a potent vasodilator. We
demonstrated that the plasma TXB2 (a metabolite of
TXA2)/6-keto-PGF1α (a metabolite of PGI2) increased 36%
in writhing animal mice model mice, which was related to the reduced blood flow velocity and
the raised pulsatility index.At last, what is particularly worth mentioning on this animal model is the fact that
uterine ultrasound did not show any visible pelvic lesions, which is in line with the
clinical diagnosis of PD.Oxytocin-induced in vivo pain model in female mice with estrogen
pretreatment recapitulates the pathophysiology and clinical features of PD, providing an
experimental model to study dysmenorrheic abdominal pain. However, the experimental models
of disease have weaknesses and PD modeling is no exception. For example, it is an acute
animal model and the writhing response only continued for about 30 min. It’s impossible to
observe the pharmacokinetic features of the test drugs by this model. There are limitations
to this study, and in future, we will further observe more indicators to compare the
similarity to humanPD, such as the uterine peristalsis evaluated with Cine-Mode-Display MR
Imaging.
Conflicts of interest
The authors declare no conflict of interest.This work was supported by a grant from Ministry of Education, the New Teachers’ Fund for
Ph. D Stations (Program No. 20110096120011), 2011’Program for Excellent Scientific and
Technological Innovation Team of Jiangsu Higher Education.
Authors: Li Chen; Suren R Sooranna; Kaiyu Lei; Mandeep Kandola; Phillip R Bennett; Zhiqing Liang; Dimitri Grammatopoulos; Mark R Johnson Journal: J Cell Mol Med Date: 2012-07 Impact factor: 5.310
Authors: Zili Xie; Jing Feng; Tao Cai; Ronald McCarthy; Mark D Eschbach; Yuhui Wang; Yonghui Zhao; Zhihua Yi; Kaikai Zang; Yi Yuan; Xueming Hu; Fengxian Li; Qin Liu; Aditi Das; Sarah K England; Hongzhen Hu Journal: JCI Insight Date: 2022-05-23